Description

Avian influenza A H5N1 is a potentially lethal pathogen with clinical and virologic features different from strains causing annual outbreaks. Early recognition of cases allows for early introduction of preventive measures which can reduce the extent of the disease.


 

Exposure history:

(1) travel to an endemic area

(2) contact with poultry

(3) contact with a sick bird

(4) contact with a sick pig or other animal

(5) contact with a sick human with a respiratory tract infection

 

Patients most seriously affected: young with no or few comorbid conditions

 

Clinical findings:

(1) cough, often productive

(2) fever

(3) dyspnea

(4) GI symptoms, with nausea, vomiting, abdominal pain and/or diarrhea

(5) variable sore throat and rhinorrhea

(6) variable headache

(7) variable myalgias

(8) rapid progression to ARDS and respiratory failure

(9) high mortality rate (up to 50-60%)

 

Radiologic findings:

(1) unilateral or bilateral infiltrate, often extensive

 

Laboratory findings:

(1) lymphopenia

(2) thrombocytopenia

(3) negative rapid test for Influenza, or positive reaction for Influenza A (a positive result for Influenza B would be against the diagnosis)

(4) elevation of serum ALT and AST

(5) negative findings for other pathogens

 

Pathology findings:

(1) hemorrhagic pneumonia

(2) hemophagocytosis in a bone marrow biopsy

 

If a patient meets these criteria:

(1) Place the patient under droplet precautions with careful hand hygiene.

(2) Consider therapy with an appropriate antiviral agent (oseltamivir or zanamivir).

(3) Send samples for viral confirmation and identification.

(4) Communicate with public health officials.

(5) Consider introducing social distancing measures in the community.

 


To read more or access our algorithms and calculators, please log in or register.